GLG Partners’s Pfizer PFE Stock Holding History

GLG Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$611K	Buy	+17,785	New	+$606K	0.03%	322
2017 Q2	–	Sell	-62,186	Closed	-$2.02M	–	404
2017 Q1	$2.02M	Hold	62,186	–	–	0.09%	231
2016 Q4	$1.92M	Sell	62,186 -24,769	-28%	-$756K	0.08%	230
2016 Q3	$2.79M	Sell	86,955 -131,043	-60%	-$4.38M	0.09%	260
2016 Q2	$7.28M	Sell	217,998 -116,042	-35%	-$3.7M	0.22%	141
2016 Q1	$9.39M	Sell	334,040 -242,873	-42%	-$6.94M	0.27%	106
2015 Q4	$17.7M	Buy	576,913 +348,184	+152%	+$11M	0.56%	55
2015 Q3	$6.82M	Buy	228,729 +146,612	+179%	+$4.7M	0.18%	137
2015 Q2	$2.61M	Buy	+82,117	New	+$2.68M	0.07%	267
2014 Q2	–	Sell	-2,499	Closed	-$76K	–	420
2014 Q1	$76K	Buy	+2,499	New	+$74.5K	﹤0.01%	344
2013 Q3	–	Sell	-107,547	Closed	-$2.86M	–	237
2013 Q2	$2.86M	Buy	+107,547	New	+$2.97M	0.11%	159

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

GLG Partners's PFE Position: Q4 2017 in Review

GLG Partners opened a new position in Pfizer (PFE) in Q4 2017: 17,785 shares worth $611K. The stake represents 0.03% of the portfolio and ranks #322 among its holdings. This is a return to the name: GLG Partners previously reported a position in PFE as recently as Q1 2017.

GLG Partners first reported a position in PFE in Q2 2013 and has held it in 11 quarters since. The position peaked at $17.7M in Q4 2015. 2,244 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

GLG Partners held 17,785 shares of Pfizer worth $611K as of Q4 2017.
Pfizer was a new GLG Partners position in Q4 2017.
Pfizer made up 0.03% of GLG Partners's portfolio in Q4 2017, its #322 holding.
GLG Partners first reported a position in Pfizer in Q2 2013 and has held it in 11 quarters since.
GLG Partners's Pfizer position peaked at $17.7M in Q4 2015.
2,244 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.